Skip to main content

Closed

EDIT: Editas Medicine, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-297.5%

ROIC-93.0%

Financially safe

Strong

Debt / equity16.33×

Interest coverage100.6×

Current ratio3.22×

Editas Medicine, Inc.

EDITNASDAQ·USD·Closed

Editas Medicine, Inc.

EDITNASDAQ·USD·Closed

$2.58

−4.09%

$2.58

−$0.11 (4.09%)

52W Range

32thpctl

Volume

0.47×avg

Mkt Cap

252.58MUSD

P/E

-2.1TTM

Div Yield

–ann

52W Range

32thpctl

Volume

0.47×avg

Market Cap

252.58MUSD

P/E Ratio

-2.1TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings